14
Views
44
CrossRef citations to date
0
Altmetric
Original Article

Survival Curves for Clonogenic Cells of a Murine Keratinizing Squamous Carcinoma Irradiated in Vivo or under Hypoxic Conditions

, &
Pages 535-549 | Received 15 Jun 1967, Published online: 03 Jul 2009
 

Summary

In its histological character and tendency to metastasize preferentially to lymph nodes, this tumour is indistinguishable from its clinical homologue. Of the morphologically intact cells released from the tumours by enzymatic treatment, 17 were required for 50 per cent successful transplantation to syngeneic hosts; this figure was reduced to 4 when a preponderance of radiation-killed cells was added to the inocula. The survival curve for cells of tumours irradiated in situ under hypoxic conditions gave D0 = 340 R and n = about 2·0. The distribution of cell-survival values for tumours irradiated in vivo indicated that about 18 per cent of the viable tumour cells are hypoxic in vivo. Four out of five different stromated tumours for which similar data have been reported had between 15 and 21 per cent of their cells hypoxic in vivo. An attempt is made to explain these striking similarities in terms of a common micro-anatomical unit with dimensions referred to the limiting distance of diffusion of oxygen from a capillary into respiring tissue, as calculated by Thomlinson and Gray (1955).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.